Cargando…
Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy
INTRODUCTION: The role of the progesterone receptor (PR) in breast cancer remains a major clinical challenge. Although PR induces mammary tumor growth, its presence in breast tumors is a marker of good prognosis. We investigated coordinated PR rapid and nonclassical transcriptional effects governing...
Autores principales: | Díaz Flaqué, María C, Galigniana, Natalia M, Béguelin, Wendy, Vicario, Rocío, Proietti, Cecilia J, Russo, Rosalía Cordo, Rivas, Martín A, Tkach, Mercedes, Guzmán, Pablo, Roa, Juan C, Maronna, Esteban, Pineda, Viviana, Muñoz, Sergio, Mercogliano, María Florencia, Charreau, Eduardo H, Yankilevich, Patricio, Schillaci, Roxana, Elizalde, Patricia V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978912/ https://www.ncbi.nlm.nih.gov/pubmed/24345432 http://dx.doi.org/10.1186/bcr3587 |
Ejemplares similares
-
Retraction Note: Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy
por: Flaqué, María C. Díaz, et al.
Publicado: (2023) -
Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer
por: Schillaci, Roxana, et al.
Publicado: (2012) -
Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth
por: Izzo, Franco, et al.
Publicado: (2014) -
ODP551 Halting ErbB-2 Isoforms Retrograde Transport to the Nucleus as a New Theragnostic Approach for Triple Negative Breast Cancer
por: Elizalde, Patricia Virginia, et al.
Publicado: (2022) -
Nuclear ErbB-2-Induced Transcriptome Drives Triple Negative Breast Cancer Growth
por: Chervo, Maria F, et al.
Publicado: (2021)